Noninvasive Prenatal Paternity Testing with a Combination of Well-Established SNP and STR Markers Using Massively Parallel Sequencing

Xuefeng Shen,Ran Li,Haixia Li,Yu Gao,Hui Chen,Ning Qu,Dan Peng,Riga Wu,Hongyu Sun
DOI: https://doi.org/10.3390/genes12030454
IF: 4.141
2021-03-22
Genes
Abstract:Cell-free fetal DNA (cffDNA) from maternal plasma has made it possible to develop noninvasive prenatal paternity testing (NIPPT). However, most studies have focused on customized single nucleotide polymorphism (SNP) typing systems and few have used conventional short tandem repeat (STR) markers. Based on massively parallel sequencing (MPS), this study used a widely-accepted forensic multiplex assay system to evaluate the effect of noninvasive prenatal paternity testing with a combination of well-established SNP and STR markers. Using a ForenSeq DNA Signature Prep Kit, NIPPT was performed in 17 real parentage cases with monovular unborn fetuses at 7 to 24 gestational weeks. Different analytical strategies for the identification of paternally inherited allele (PIA) were developed to deal with SNPs and STRs. Combined paternity index (CPI) for 17 real trios as well as 272 unrelated trios was calculated. With the combination of SNPs and A-STRs, 82.35% (14/17), 88.24% (15/17), 94.12% (16/17), and 94.12% (16/17) of real trios could be accurately determined when the likelihood ratio (LR) threshold for paternity inclusion was set to 10,000, 1000, 100, and 10, respectively. This reveals that simultaneous surveys of SNP and STR markers included in the ForenSeq DNA Signature Prep Kit offer a promising method for NIPPT using MPS technology.
genetics & heredity
What problem does this paper attempt to address?
The paper aims to address several key issues in non-invasive prenatal paternity testing (NIPPT). Specifically: 1. **Reducing risks to the mother and fetus**: Traditional prenatal paternity testing methods such as amniocentesis and chorionic villus sampling carry certain risks, potentially leading to miscarriage, fetal respiratory distress, and other complications. Therefore, the paper explores a non-invasive prenatal paternity testing method based on cell-free fetal DNA (cffDNA) in maternal plasma to reduce these risks. 2. **Improving the accuracy and sensitivity of detection**: Although previous studies have used single nucleotide polymorphism (SNP) markers for NIPPT, these studies mostly rely on custom SNP genotyping systems that are not widely accepted and have data sharing difficulties. Additionally, the polymorphism of SNP markers is limited, requiring a large number of markers to achieve high accuracy. The paper proposes a method that combines established short tandem repeat (STR) markers and SNP markers, utilizing massively parallel sequencing (MPS) technology to improve the accuracy and sensitivity of detection. 3. **Optimizing the application of STR markers in NIPPT**: STR markers are commonly used genetic markers in paternity testing, but their application in NIPPT is limited mainly due to their longer amplicon lengths and the presence of stutter artifacts. The paper optimizes the application of STR markers in NIPPT by using the ForenSeq DNA Signature Prep Kit, which includes shorter amplicons, and developing new analytical strategies to identify STR alleles. 4. **Establishing unified standards and evaluation systems**: The paper attempts to establish a widely recognized NIPPT panel and unified evaluation standards for better application in forensic practice. By combining SNP and STR markers, the paper demonstrates the effectiveness and reliability of this method in actual cases. In summary, the main goal of the paper is to develop an efficient, accurate, and easily promotable non-invasive prenatal paternity testing method by combining established SNP and STR markers and utilizing MPS technology, thereby reducing the risks of traditional methods and improving the accuracy and sensitivity of detection.